AURELIUS Equity Opportunities SE & Co. KGaA (XTRA:AR4) acquired Admenta UK Limited from McKesson Europe AG (HMSE:CLS1) on April 13, 2022. McKesson has an established position in the UK healthcare sector through Admenta UK Ltd, and the UK group generated over £5 billion in revenues in FY March 2022. Barclays played a key role in funding the acquisition, as Sole Lead Arranger on a £357.5 million syndicated Asset Based Finance facility (made up of £268 million of receivables funding and £89 million of inventory funding). The five other syndicate members were: ABN AMRO Commercial Finance; BNP Paribas Commercial Finance Limited; HSBC Invoice Finance (UK) Limited; RBS Invoice Finance Limited; and Secure Trust Bank PLC. Interpath Advisory acted as financial advisor to Admenta UK Limited.

AURELIUS Equity Opportunities SE & Co. KGaA (XTRA:AR4) completed the acquisition of Admenta UK Limited from McKesson Europe AG (HMSE:CLS1) on April 13, 2022.